Global Seasonal Influenza Vaccine
Market Report
2024
Seasonal Influenza Vaccine Market Report 2024 (Global Edition)
The Global Seasonal Influenza Vaccine market size was $7.0 billion in 2022 and it is forecasted to reach $12.1 billion by 2030. The seasonal Influenza Vaccine Industry's Compound Annual Growth Rate will be 6.99 % from 2023 to 2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
|
Rating: 4.8 | Review: 6
Share your contact details to receive free updated sample copy/pages of the recently published edition of Seasonal Influenza Vaccine Market Report 2024.
Global Seasonal Influenza Vaccine Market Report 2024 Market Size Split by Product Type (Type A (H1N1), Type A (H3N2), Type B), by Age Group (Paediatrics, Adolescence, Adults, Elderly), by Vaccine Type...
As per Cognitive Market Research's latest published report, The Global Seasonal Influenza Vaccine market size was $7.0 billion in 2022 and it is forecasted to reach $12.1 billion by 2030.The seasonal Influenza Vaccine Industry's Compound Annual Growth Rate will be 6.99 % from 2023 to 2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Seasonal Influenza Vaccine Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.99% |
| Market Split by Product Type |
|
| Market Split by Age Group |
|
| Market Split by Vaccine Type |
|
| Market Split by End-users |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Seasonal Influenza Vaccine industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Seasonal Influenza Vaccine Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Seasonal Influenza Vaccine Market Report Description
Introduction of Seasonal Influenza Vaccine
Seasonal influenza vaccine is referred as the flu shot which is a vaccine indicated for the protection from the seasonal flu. The vaccine is given with a needle, usually in the arm to protect the person from Influenza. Influenza is a term used for the acute respiratory illness, commonly affect the upper and/or lower respiratory tract. The influenza is caused by the influenza virus which circulates in temperate regions and some tropical regions leading to the seasonal epidemics and year-round epidemics.
The influenza virus is potential to show various mutation and hence to better match the currently floating influenza strains, the manufacturers are advised to change the vaccine strains annually. The seasonal influenza vaccine is potent against the three or four influenza viruses which are most common in the upcoming season.
There are two types of influenza vaccine which are mostly available, inactivated influenza vaccines (IIV) and live attenuated influenza vaccines (LAIV) and these are indicated to administered annually to provide optimal protection against infection.
Normally the symptoms seen in the influenza patients are high fever, chills, body aches, sore throat, cough, fatigue etc. Most of the people recover in a few days or in less than 14 days, but in some people the complications such as pneumonia, ear infections, myocarditis, myositis, rhabdomyolysis etc. are develop which is life-threatening and may also lead to the death of patient. Hence the annual shots of influenza vaccine are recommended for the pediatric and geriatrics group and the people associated with the other disease conditions. In the northern hemisphere, annual influenza epidemics occur during autumn and winter affecting approximately 5-15% of the population.
Seasonal influenza vaccine is segmented into various main categories which includes Vaccine Type (Trivalent flu vaccines and Quadrivalent flu vaccines), by Virus Type (Influenza Virus Type A, Influenza Virus Type B), by Age Group (Pediatrics, Adults), by End User (Hospitals, Clinics, Ambulatory care centers) and by technology (egg-based, cell-culture based, recombinant).
The increasing awareness among the population, government involvement for the well-being its citizens, increasing investment in research and development activities by companies are few factors which are leading the growth of market and is expected to show the potential growth in the coming years.
Factors Affecting Seasonal Influenza Vaccine Market Growth
- Increasing prevelance of influenza cases and various government projects
The market demand has grown as a result of a seasonal outbreak's increase in influenza cases. Seasonal influenza vaccines are high in demand on the market as a result of the public's rising awareness of the disease. Developing and developed countries are due to the increased focus of industrialists, as these are standardized according to the specific virus strain. This characteristic of the vaccines helps minimize the flu in less time and revert positive effects. Additionally, the market has been given a boost by the rise of various government projects.
- Growing Immunization Programs & Increased R&D
Immunization is a method used to increase a person’s immunity and reduce the spread of infectious diseases. Vaccines are used to prevent certain diseases. In 2018, the Government of India launched a comprehensive multi-year plan to reduce mortality and morbidity due to vaccine-preventable diseases and ensure vaccination coverage of more than 90% of the population in the country. Additionally, in the US, 2019, WHO launched the Polio Endgame Strategy 2019-2023 to immunize children and eradicate polio.
Research & development (R&D) is a major department in pharmaceutical and biotechnology companies. mRNA technology is widely used for the development of the vaccines. It is responsible for the development of new medicines, molecules, and vaccines for the treatment of influenza diseases. Rise in the prevalence of infectious and chronic diseases propels the need for the introduction of combination vaccines, including the mRNA vaccines, which in turn, boosts the demand for vaccines. The mRNA technology is also used for the development of seasonal influenza vaccines. There are several benefits of using the mRNA in the vaccines, which is one of the significant factors, driving the growth of the market
The restraining factor of the Seasonal Influenza Vaccine market
-
The high cost of Seasonal Influenza Vaccine may hamper the growth of the market
The high cost of vaccine development is expected to hinder the growth of the market. The Centers for Disease Control and Prevention (CDC) paid a greater price than in prior seasons for seven million doses of vaccine when it bought the vaccine in bulk through agreements for the flu season.
Impact of the COVID-19 Pandemic on the seasonal influenza vaccine Market
The global COVID-19 outbreak and thea closure situation in some countries are expected to have a negative impact on the market owing to the increased demand for influenza vaccines during the pandemic. Influenza vaccine demand is rising due to heightened public awareness of the threat posed by respiratory viruses to the elderly and those with comorbidities, as well as the potential burden on healthcare services of coinciding COVID and influenza waves.
We have various report editions of Seasonal Influenza Vaccine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Seasonal Influenza Vaccine Market Insights Video
Competitive Analysis of the Seasonal Influenza Vaccine Market:
Company Recent Developments:
-
The effectiveness of seasonal influenza vaccine against the h3n2 influenza virus
In 2023,H3N2 VIRUS is a non-human influenza virus that normally circulates in pigs and that has infected humans. Influenza A (H3N3) is responsible for the present rise in flu cases as notified by ICMR. Both H1N1 and H3N2 sub-types are variants of influenza A which change genetically as well as antigenically to produce new variants. H3N2 tends to change more rapidly, both genetically and antigenically, compared to H1N1. H3N2 is the cause behind the rise in flu cases that we have been seeing recently.
- The development of universal vaccines represents an emerging trend in influenza
In June 2023,Universal influenza vaccines are created to provide protection against more strains of the virus than quadrivalent influenza vaccines. The antibodies produced as a result of these universal influenza vaccinations should be able to recognize conserved epitopes on the surface of various influenza strains. This would be particularly advantageous in the event of an influenza pandemic arising from a new strain.
Top Companies Market Share in Seasonal Influenza Vaccine Industry: (In no particular order of Rank)
- Sanofi
- Merck & Co
- Novartis
- GlaxoSmithKline
- Changsheng Bio-Technology Co.
- Abbott Laboratories
- Aleph Biomedical
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Seasonal Influenza Vaccine Market Regional Analysis
Region and country analysis section of Seasonal Influenza Vaccine Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Seasonal Influenza Vaccine market.
The current report Scope analyzes Seasonal Influenza Vaccine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Seasonal Influenza Vaccine Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Seasonal Influenza Vaccine Market Analysis
Global Seasonal Influenza Vaccine Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Seasonal Influenza Vaccine Industry growth. Seasonal Influenza Vaccine market has been segmented with the help of its Product Type, Age Group Vaccine Type, and others. Seasonal Influenza Vaccine market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Type A (h1n1) was the leading category of Seasonal Influenza Vaccine market category.
The most common seasonal influenza is Type A (h1n1), and the market for type A seasonal influenza vaccine is on an exponential rise.
Seasonal Influenza Vaccine Market, by Type
- Type A (H1N1)
- Type A (H3N2)
- Type B
Seasonal Influenza Vaccine Market Share (%) by Product Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Seasonal Influenza Vaccine Industry. Request a Free Sample PDF!
By Age, Adult segment dominates the Seasonal Influenza Vaccine market.
The various types of seasonal influenza vaccine are prepared for different age group people. The different set of vaccine are available for the adult which fall in the age group from 18- 64 years. The people with certain chronic health conditions and pregnant women are advice to take the influenza vaccine. Only the people having life threating allergy to the vaccine or its component are advice not to take the vaccine.
Pediatrics
The Seasonal Influenza Vaccine reduces the risk of flu-associated complications and hospitalization among children. It is recommended that the children above the 6 months of age should be vaccinated every year in the fall i.e., by the end of October. The children ranging between the age group from 6 month to 8 years may require 2 doses of influenza vaccines for best protection.
Seasonal Influenza Vaccine market by Age segment analysis
- Paediatrics
- Adolescence
- Adults
- Elderly
Seasonal Influenza Vaccine Market Share (%) by Age Group in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Seasonal Influenza Vaccine Vaccine Type Segment Analysis
What is the Quadrivalent Flu Vaccines Market size?
Quadrivalent Flu Vaccines
In 2016, the Quadrivalent Flu Vaccines Revenue (USD Million) was USD 3,276.45 Million and is expected to reach USD 9,511.01 Million in 2030.
Quadrivalent flu vaccines are capable of protecting against four different strains of the flu virus which includes two influenza A viruses and two influenza B viruses and hence can offers broader protection from infection. The Regular standard-dose quadrivalent shot are available for the population of age 6 months and older
Trivalent Flu Vaccines
Trivalent flu vaccines offer the protection from three strains of the virus which includes influenza A (H1N1), influenza A (H3N2), an influenza B virus. This vaccine is intended to administer in the muscle of arms via needle and is indicated for the people ranging in the age group of 10-64.
- Quadrivalent
- Trivalent
- High-Dose
Seasonal Influenza Vaccine End-users Segment Analysis
As per Analysis ,Hospitals segment accounted for 68.09% share of total Seasonal influenza vaccine market in 2030
Hospitals segment accounted for 68.09% share of total Seasonal influenza vaccine market in 2030. Hospitals is a term use for a residential establishment which provides short-term and long-term medical care consisting of observational, diagnostic, therapeutic and rehabilitative services for persons suffering or suspected to be suffering from a disease or injury and for patients. Hospital generally provides wide range of various type of healthcare and care for patients with various disease condition such as orthopedic, cardiology, dental, gynecology etc.
Clinics
Specialist clinics refers to the services provided to the outpatients. These are generally associated with hospital or medical school, that is devoted to the diagnosis and care of outpatients
Ambulatory care centers
It is a modern healthcare facility which offers the same-day surgical care, including diagnostic and preventive procedures. These centers provide diagnostic or primary health care services to the patients who have already seen a health care provider and selected surgery as the appropriate treatment for their condition.
- Hospitals
- Clinics
- Ambulatory care centers
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Bio :
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Seasonal Influenza Vaccine Market is witnessing significant growth in the near future.
In 2023, the Type A (H1N1) segment accounted for noticeable share of global Seasonal Influenza Vaccine Market and is projected to experience significant growth in the near future.
The Paediatrics segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Sanofi , Novartis and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions (FAQs)
Changing weather conditions and rapid transmission of diseases have led to an increase in the rising cases of seasonal influenza, which in turn has led to an increase in demand for the Seasonal Influenza Vaccine Market.
The major key players included in this market are Sanofi, Merck & Co, Novartis, GlaxoSmithKline, Changsheng Bio-Technology Co., Ltd., Abbott Laboratories, and Aleph Biomedical.
The market research report includes qualitative and qualitative insights into the industry. Top-down and bottom-up approaches were used to estimate and validate the size of the seasonal influenza vaccine market and to estimate the size of various other dependent submarkets.
Yes, the report includes a COVID-19 impact analysis.
The report has been analyzed from the year 2022 to 2030 in which 2018-2021: Historic Period 2023: Base Year
Seasonal flu vaccines are designed to protect against infection and illness caused by the flu viruses that research indicates will be most common during the upcoming flu season. Flu vaccines do not protect against infection and illness caused by other viruses that also can cause flu-like symptoms.
Adults and children 9 years of age and older should receive 1 dose of influenza vaccine each year.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Seasonal Influenza Vaccine Market
Latest Articles about Seasonal Influenza Vaccine Market
Seasonal influenza vaccine is referred as the flu shot which is a vaccine indicated for the protection from the seasonal flu. The seasonal influenza vaccine is potent against the three or four influenza viruses which are most common in the upcoming season.
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Healthcare_expenditure_statistics
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
Seasonal Influenza Vaccine Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product Type | Type A (H1N1), Type A (H3N2), Type B |
| Age Group | Paediatrics, Adolescence, Adults, Elderly |
| Vaccine Type | Quadrivalent, Trivalent, High-Dose |
| End-users | Hospitals, Clinics, Ambulatory care centers |
| List of Competitors | Sanofi, Merck & Co, Novartis, GlaxoSmithKline, Changsheng Bio-Technology Co., Abbott Laboratories, Aleph Biomedical |
Expand All
This chapter will help you gain GLOBAL Market Analysis of Seasonal Influenza Vaccine. Further deep in this chapter, you will be able to review Global Seasonal Influenza Vaccine Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Seasonal Influenza Vaccine Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Seasonal Influenza Vaccine Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Seasonal Influenza Vaccine Revenue Market Size By Region
-
-
1.3 Global Seasonal Influenza Vaccine Market Size By Product Type 2019 -2031
-
1.3.1 Type A (H1N1) Market Size
-
1.3.2 Type A (H3N2) Market Size
-
1.3.3 Type B Market Size
-
-
1.4 Global Seasonal Influenza Vaccine Market Size By Age Group 2019 -2031
-
1.4.1 Paediatrics Market Size
-
1.4.2 Adolescence Market Size
-
1.4.3 Adults Market Size
-
1.4.4 Elderly Market Size
-
-
1.5 Global Seasonal Influenza Vaccine Market Size By Vaccine Type 2019 -2031
-
1.5.1 Quadrivalent Market Size
-
1.5.2 Trivalent Market Size
-
1.5.3 High-Dose Market Size
-
-
1.6 Global Seasonal Influenza Vaccine Market Size By End-users for 2019 -2031
-
1.6.1 Hospitals Market Size
-
1.6.2 Clinics Market Size
-
1.6.3 Ambulatory care centers Market Size
-
-
1.7 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.8 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.8.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.8.2 Global Market Revenue Split By Product Type
-
1.8.3 Global Market Revenue Split By Age Group
-
1.8.4 Global Market Revenue Split By Vaccine Type
-
1.8.5 Global Market Revenue Split By End-users
-
1.8.6 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Seasonal Influenza Vaccine Market Size 2019 - 2031
-
2.1.1 North America Seasonal Influenza Vaccine Market Size By Country 2019 - 2031
-
2.1.2 North America Seasonal Influenza Vaccine Market Size by Product Type 2019 -2031
-
2.1.2.1 North America Type A (H1N1) Market Size
-
2.1.2.2 North America Type A (H3N2) Market Size
-
2.1.2.3 North America Type B Market Size
-
-
2.1.3 North America Seasonal Influenza Vaccine Market Size by Age Group 2019 -2031
-
2.1.3.1 North America Paediatrics Market Size
-
2.1.3.2 North America Adolescence Market Size
-
2.1.3.3 North America Adults Market Size
-
2.1.3.4 North America Elderly Market Size
-
-
2.1.4 North America Seasonal Influenza Vaccine Market Size by Vaccine Type 2019 -2031
-
2.1.4.1 North America Quadrivalent Market Size
-
2.1.4.2 North America Trivalent Market Size
-
2.1.4.3 North America High-Dose Market Size
-
-
2.1.5 North America Seasonal Influenza Vaccine Market Size by End-users 2019 -2031
-
2.1.5.1 North America Hospitals Market Size
-
2.1.5.2 North America Clinics Market Size
-
2.1.5.3 North America Ambulatory care centers Market Size
-
-
-
2.2 Add-Ons: Customize the Report Edition
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
-
2.2.1 North America Company Market Share 2019 till 2023
-
2.2.2 Qualitative Analysis for North America Market
Qualitative Analysis for the North America Market: North America Seasonal Influenza Vaccine Market Trends North America Seasonal Influenza Vaccine Technological Road Map North America Seasonal Influenza Vaccine Market Drivers North America Seasonal Influenza Vaccine Market Restraints North America Seasonal Influenza Vaccine Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
-
-
2.3 Executive Summary North America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
-
2.3.1 North America Market Summary 2019 vs 2024 vs 2031
-
2.3.2 North America Market Revenue Split By Product Type
-
2.3.3 North America Market Revenue Split By Age Group
-
2.3.4 North America Market Revenue Split By Vaccine Type
-
2.3.5 North America Market Revenue Split By End-users
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Seasonal Influenza Vaccine Market Size 2019 - 2031
-
3.1.1 Europe Seasonal Influenza Vaccine Market Size By Country 2019 - 2031
-
3.1.2 Europe Seasonal Influenza Vaccine Market Size by Product Type 2019 -2031
-
3.1.2.1 Europe Type A (H1N1) Market Size
-
3.1.2.2 Europe Type A (H3N2) Market Size
-
3.1.2.3 Europe Type B Market Size
-
-
3.1.3 Europe Seasonal Influenza Vaccine Market Size by Age Group 2019 -2031
-
3.1.3.1 Europe Paediatrics Market Size
-
3.1.3.2 Europe Adolescence Market Size
-
3.1.3.3 Europe Adults Market Size
-
3.1.3.4 Europe Elderly Market Size
-
-
3.1.4 Europe Seasonal Influenza Vaccine Market Size by Vaccine Type 2019 -2031
-
3.1.4.1 Europe Quadrivalent Market Size
-
3.1.4.2 Europe Trivalent Market Size
-
3.1.4.3 Europe High-Dose Market Size
-
-
3.1.5 Europe Seasonal Influenza Vaccine Market Size by End-users 2019 -2031
-
3.1.5.1 Europe Hospitals Market Size
-
3.1.5.2 Europe Clinics Market Size
-
3.1.5.3 Europe Ambulatory care centers Market Size
-
-
-
3.2 Add-Ons: Customize the Report Edition
-
3.2.1 Europe Company Market Share 2019 till 2023
-
3.2.2 Qualitative Analysis for Europe Market
-
-
3.3 Executive Summary Europe Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
-
3.3.1 Europe Revenue Market Summary 2019 vs 2024 vs 2031
-
3.3.2 Europe Market Revenue Split By Product Type
-
3.3.3 Europe Market Revenue Split By Age Group
-
3.3.4 Europe Market Revenue Split By Vaccine Type
-
3.3.5 Europe Market Revenue Split By End-users
-
Chapter 4 Asia-Pacific Market Analysis
-
4.1 Asia Pacific Seasonal Influenza Vaccine Market Size 2019 - 2031
-
4.1.1 Asia Pacific Seasonal Influenza Vaccine Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Seasonal Influenza Vaccine Market Size by Product Type 2019 -2031
-
4.1.2.1 Asia Pacific Type A (H1N1) Market Size
-
4.1.2.2 Asia Pacific Type A (H3N2) Market Size
-
4.1.2.3 Asia Pacific Type B Market Size
-
-
4.1.3 Asia Pacific Seasonal Influenza Vaccine Market Size by Age Group 2019 -2031
-
4.1.3.1 Asia Pacific Paediatrics Market Size
-
4.1.3.2 Asia Pacific Adolescence Market Size
-
4.1.3.3 Asia Pacific Adults Market Size
-
4.1.3.4 Asia Pacific Elderly Market Size
-
-
4.1.4 Asia Pacific Seasonal Influenza Vaccine Market Size by Vaccine Type 2019 -2031
-
4.1.4.1 Asia Pacific Quadrivalent Market Size
-
4.1.4.2 Asia Pacific Trivalent Market Size
-
4.1.4.3 Asia Pacific High-Dose Market Size
-
-
4.1.5 Asia Pacific Seasonal Influenza Vaccine Market Size by End-users 2019 -2031
-
4.1.5.1 Asia Pacific Hospitals Market Size
-
4.1.5.2 Asia Pacific Clinics Market Size
-
4.1.5.3 Asia Pacific Ambulatory care centers Market Size
-
-
-
4.2 Add-Ons: Customize the Report Edition
-
4.2.1 Asia Pacific Company Market Share 2019 till 2023
-
4.2.2 Qualitative Analysis for Asia Pacific Market
-
-
4.3 Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
-
4.3.1 Asia Pacific Market Summary 2019 vs 2024 vs 2031
-
4.3.2 Asia Pacific Market Revenue Split By Product Type
-
4.3.3 Asia Pacific Market Revenue Split By Age Group
-
4.3.4 Asia Pacific Market Revenue Split By Vaccine Type
-
4.3.5 Asia Pacific Market Revenue Split By End-users
-
Chapter 5 South America Market Analysis
-
5.1 South America Seasonal Influenza Vaccine Market Size 2019 - 2031
-
5.1.1 South America Seasonal Influenza Vaccine Revenue Market Size By Country 2019 - 2031
-
5.1.2 South America Seasonal Influenza Vaccine Market Size by Product Type 2019 -2031
-
5.1.2.1 South America Type A (H1N1) Market Size
-
5.1.2.2 South America Type A (H3N2) Market Size
-
5.1.2.3 South America Type B Market Size
-
-
5.1.3 South America Seasonal Influenza Vaccine Market Size by Age Group 2019 -2031
-
5.1.3.1 South America Paediatrics Market Size
-
5.1.3.2 South America Adolescence Market Size
-
5.1.3.3 South America Adults Market Size
-
5.1.3.4 South America Elderly Market Size
-
-
5.1.4 South America Seasonal Influenza Vaccine Market Size by Vaccine Type 2019 -2031
-
5.1.4.1 South America Quadrivalent Market Size
-
5.1.4.2 South America Trivalent Market Size
-
5.1.4.3 South America High-Dose Market Size
-
-
5.1.5 South America Seasonal Influenza Vaccine Market Size by End-users 2019 -2031
-
5.1.5.1 South America Hospitals Market Size
-
5.1.5.2 South America Clinics Market Size
-
5.1.5.3 South America Ambulatory care centers Market Size
-
-
-
5.2 Add-Ons: Customize the Report Edition
-
5.2.1 South America Company Market Share 2019 till 2023
-
5.2.2 Qualitative Analysis for South America Market
-
-
5.3 Executive Summary South America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
-
5.3.1 South America Market Summary 2019 vs 2024 vs 2031
-
5.3.2 South America Market Revenue Split By Product Type
-
5.3.3 South America Market Revenue Split By Age Group
-
5.3.4 South America Market Revenue Split By Vaccine Type
-
5.3.5 South America Market Revenue Split By End-users
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Seasonal Influenza Vaccine Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Seasonal Influenza Vaccine Revenue Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Seasonal Influenza Vaccine Market Size by Product Type 2019 -2031
-
6.1.2.1 Middle East and Africa Type A (H1N1) Market Size
-
6.1.2.2 Middle East and Africa Type A (H3N2) Market Size
-
6.1.2.3 Middle East and Africa Type B Market Size
-
-
6.1.3 Middle East and Africa Seasonal Influenza Vaccine Market Size by Age Group 2019 -2031
-
6.1.3.1 Middle East and Africa Paediatrics Market Size
-
6.1.3.2 Middle East and Africa Adolescence Market Size
-
6.1.3.3 Middle East and Africa Adults Market Size
-
6.1.3.4 Middle East and Africa Elderly Market Size
-
-
6.1.4 Middle East and Africa Seasonal Influenza Vaccine Market Size by Vaccine Type 2019 -2031
-
6.1.4.1 Middle East and Africa Quadrivalent Market Size
-
6.1.4.2 Middle East and Africa Trivalent Market Size
-
6.1.4.3 Middle East and Africa High-Dose Market Size
-
-
6.1.5 Middle East and Africa Seasonal Influenza Vaccine Market Size by End-users 2019 -2031
-
6.1.5.1 Middle East and Africa Hospitals Market Size
-
6.1.5.2 Middle East and Africa Clinics Market Size
-
6.1.5.3 Middle East and Africa Ambulatory care centers Market Size
-
-
-
6.2 Add-Ons: Customize the Report Edition
-
6.2.1 Middle East and Africa Company Market Share 2019 till 2023
-
6.2.2 Qualitative Analysis for Middle East and Africa Market
-
-
6.3 Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
-
6.3.1 Middle East and Africa Market Summary 2019 vs 2024 vs 2031
-
6.3.2 Middle East and Africa Market Revenue Split By Product Type
-
6.3.3 Middle East and Africa Market Revenue Split By Age Group
-
6.3.4 Middle East and Africa Market Revenue Split By Vaccine Type
-
6.3.5 Middle East and Africa Market Revenue Split By End-users
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Seasonal Influenza Vaccine Market Size by Product Type 2019 -2031
-
7.1.2 Country 1Seasonal Influenza Vaccine Market Size by Age Group 2019 -2031
-
7.1.3 Country 1Seasonal Influenza Vaccine Market Size by Vaccine Type 2019 -2031
-
7.1.4 Country 1Seasonal Influenza Vaccine Market Size by End-users 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Seasonal Influenza Vaccine Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Sanofi
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Merck & Co
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Novartis
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 GlaxoSmithKline
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Changsheng Bio-Technology Co.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Abbott Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Aleph Biomedical
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Product Type Analysis 2019 -2031, will provide market size split by Product Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Type Analysis 2019 -2031
-
10.1 Type A (H1N1)
-
10.1.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Type A (H1N1) 2019 -2031
-
-
10.2 Type A (H3N2)
-
10.2.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Type A (H3N2) 2019 -2031
-
-
10.3 Type B
-
10.3.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Type B 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Age Group Analysis 2019 -2031
-
11.1 Paediatrics
-
11.1.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Paediatrics 2019 - 2031
-
-
11.2 Adolescence
-
11.2.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Adolescence 2019 - 2031
-
-
11.3 Adults
-
11.3.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Adults 2019 - 2031
-
-
11.4 Elderly
-
11.4.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Elderly 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Vaccine Type Analysis 2019 -2031
-
12.1 Quadrivalent
-
12.1.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Quadrivalent 2019 -2031
-
-
12.2 Trivalent
-
12.2.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Trivalent 2019 -2031
-
-
12.3 High-Dose
-
12.3.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by High-Dose 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by End-users Analysis 2019 -2031
-
13.1 Hospitals
-
13.1.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Hospitals 2019 -2031
-
-
13.2 Clinics
-
13.2.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Clinics 2019 -2031
-
-
13.3 Ambulatory care centers
-
13.3.1 Global Seasonal Influenza Vaccine Revenue Market Size and Share by Ambulatory care centers 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Seasonal Influenza Vaccine market
Chapter 14 Research Findings
-
14.1 Key Takeaways
-
14.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
14.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
Research Methodology Implemented by Manjiri Kanhere and Team
- 1.1 Seasonal Influenza Vaccine Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Seasonal Influenza Vaccine Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Seasonal Influenza Vaccine Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Seasonal Influenza Vaccine Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Seasonal Influenza Vaccine Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Seasonal Influenza Vaccine Market
Key Questions Answered By Seasonal Influenza Vaccine Market Report 2024
| Why Type A (H1N1) have a significant impact on Seasonal Influenza Vaccine market? |
| What are the key factors affecting the Type A (H1N1) and Type A (H3N2) of Seasonal Influenza Vaccine Market? |
| What is the CAGR/Growth Rate of Paediatrics during the forecast period? |
| By type, which segment accounted for largest share of the global Seasonal Influenza Vaccine Market? |
| Which region is expected to dominate the global Seasonal Influenza Vaccine Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
